WADA status BPC-157 BPC-157 has no approval from any governmental regulatory health authority for human therapeutic use, and as such falls under WADA category S0 (Non-Approved Substances), prohibited at all times (ref
Int J Mol Sci 2020;21:1170
Energy-Based Devices : Ultherapy (ultrasound), Sofwave, and radiofrequency microneedling trigger dermal remodeling, improving skin tightening without surgery
Nutrients may help improve mitochondrial function, thereby alleviating brain energy metabolism deficits and oxidative stress in migraine
A revitalizing boost from within
The First Triple G-Agonist In their Nature Medicine editorial this week A Revolution in Obesity Treatment, Lingvay and Agarwal highlighted the results of the first triple incretin-like drugretatrutidewith completed Phase 2 randomized trials